Bit Capital Gmb H Black Diamond Therapeutics, Inc. Transaction History

Bit Capital Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$2.14 - $4.17 $307,684 - $599,554	-143,778 Closed	0 $0
Q3 2024 Feb 12, 2025	SELL	$4.2 - $6.58 $460,387 - $721,273	-109,616 Reduced 43.26%	143,778 $625 Million
Q2 2024 Feb 12, 2025	SELL	$4.65 - $7.39 $101,895 - $161,937	-21,913 Reduced 7.96%	253,394 $1.18 Billion
Q1 2024 Feb 12, 2025	BUY	$2.67 - $5.74 $735,069 - $1.58 Million	275,307 New	275,307 $1.4 Billion

123

49.1M

1.84M

1.93M

Ticker BDTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,339,500
Market Cap $80.3M
Description
Black Diamond Therapeutics, Inc., a biotechnology company, discover, develops, and commercializes medicines for patient with genetically defined tumors. It develops BDTX-189, an irreversible small molecule inhibitor that is designed to targets oncogenic proteins defined by the non-canonical epidermal growth factor receptor (EGFR) and human epide...

Get notified when there are updates to the investment portfolio of Bit Capital Gmb H, based on Form 13F filings with the SEC.

Stay updated on Bit Capital Gmb H with notifications on news.